Book contents
- Frontmatter
- Contents
- List of Contributors
- Preface
- Acknowledgements
- Part I Operations within Organisations – Building Blocks
- Part II Approaches to Understanding OM
- Part III Moving Forward with OM – Creating Competitive Advantage
- Part IV Challenges and Opportunities in Operations
- Part V Case Studies
- 1 Innovation in the Biotechnology Sector: The Case of IDT Australia
- 2 New Zealand King Salmon: Value-Chain Innovation
- 3 Pilila Clothing Company Goes Lean
- 4 From Singapore to the World: Port Management in Singapore
- 5 Striving for Operations Excellence within Queensland Rail Supply Division
- 6 Should I Stay or Should I Go? Shiraishi Garments Company
- 7 Towards a Green Supply Chain: Toyota Australia
- 8 Process Analyses and Improvement at Bartter Enterprises
- 9 Operations Challenges at Firth Industries Limited, Wellington Division
- 10 Ford Motor Company: Moving Forward in Australia
- 11 Technology Transfer at Hero Honda
- 12 Why Is the Patient Resident Time so Long?: The Case of St Martin's and Charity Private Hospital
- Index
- References
1 - Innovation in the Biotechnology Sector: The Case of IDT Australia
Published online by Cambridge University Press: 05 June 2012
- Frontmatter
- Contents
- List of Contributors
- Preface
- Acknowledgements
- Part I Operations within Organisations – Building Blocks
- Part II Approaches to Understanding OM
- Part III Moving Forward with OM – Creating Competitive Advantage
- Part IV Challenges and Opportunities in Operations
- Part V Case Studies
- 1 Innovation in the Biotechnology Sector: The Case of IDT Australia
- 2 New Zealand King Salmon: Value-Chain Innovation
- 3 Pilila Clothing Company Goes Lean
- 4 From Singapore to the World: Port Management in Singapore
- 5 Striving for Operations Excellence within Queensland Rail Supply Division
- 6 Should I Stay or Should I Go? Shiraishi Garments Company
- 7 Towards a Green Supply Chain: Toyota Australia
- 8 Process Analyses and Improvement at Bartter Enterprises
- 9 Operations Challenges at Firth Industries Limited, Wellington Division
- 10 Ford Motor Company: Moving Forward in Australia
- 11 Technology Transfer at Hero Honda
- 12 Why Is the Patient Resident Time so Long?: The Case of St Martin's and Charity Private Hospital
- Index
- References
Summary
Introduction
The Institute of Drug Technology was a university-owned not-for-profit organisation which operated as part of the College of Pharmacy in Victoria since 1975. It primarily gave academics and industry the chance to conduct research and development together. In 1986, then a professor, Dr Graeme L. Blackman led a management buy-out of the assets of this consulting business. The company was listed on the Australian Stock Exchange in 1988 as IDT.
From 1988 to the early 1990s, there was a move away from an academic orientation and towards a manufacturing focus. This was because the company was commissioned to make active pharmaceutical ingredients (APIs) under long-term manufacturing contracts. As a result, the company integrated forward from a licensor of technology to a production oriented company.
The company has a number of modern manufacturing facilities and laboratories in Melbourne and is licensed by the Australian Therapeutic Goods Administration (TGA) and the United States Food and Drug Administration (FDA) for the production of active pharmaceutical ingredients. IDT is one of the few Australian-owned biotechnology companies that have secured FDA approval, which gives it access to the large and lucrative pharmaceutical market in the United States.
- Type
- Chapter
- Information
- Operations ManagementAn Integrated Approach, pp. 409 - 418Publisher: Cambridge University PressPrint publication year: 2008